Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 8, 2009, Pages 1291-1308

  Walker, D L ^a   Miles, L A ^a,b   Davis, M ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Amygdala; Anxiety; Bed nucleus of the stria terminalis; Corticotropin releasing factor; Startle

Indexed keywords

AMPA RECEPTOR; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; GLUTAMIC ACID; PROTEIN FOS;

AMYGDALOID NUCLEUS; ANXIETY; ARTICLE; ASSOCIATION; BED NUCLEUS OF THE STRIA TERMINALIS; CHRONIC STRESS; CONDITIONED REFLEX; EXCITOTOXICITY; HUMAN; MEMORY CONSOLIDATION; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVE PROJECTION; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PHOTOSTIMULATION; PLACE PREFERENCE; SOCIAL BEHAVIOR; STARTLE REFLEX; STIMULUS RESPONSE; STRIA TERMINALIS;

AMYGDALA; ANIMALS; ANXIETY; CORTICOTROPIN-RELEASING HORMONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEAR; LIGHT; METHYLCELLULOSE; SEPTAL NUCLEI; STARTLE REACTION; STRESS, PSYCHOLOGICAL;

EID: 71549156217     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.06.022     Document Type: Article

References (179)

1. Albeck D.S., McKittrick C.R., Blanchard D.C., Blanchard R.J., Nikulina J., McEwen B.S., et al. Chronic social stress alters levels of corticotropin-releasing factor and arginine vasopressin mRNA in rat brain. J Neurosci 17 (1997) 4895-4903
2. Alheid G.F., and Heimer L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience 27 (1988) 1-39
3. Alheid G., De Olmos J.S., and Beltramino C.A. Amygdala and extended amygdala. In: Paxinos G. (Ed). The rat nervous system (1995), Academic Press, New York 495-578
4. Allen L.S., and Gorski R.A. Sex difference in the bed nucleus of the stria terminalis of the human brain. J Comp Neurol 302 (1990) 697-706
5. Anagnostaras S.G., Gale G.D., and Fanselow M.S. Hippocampus and contextual fear conditioning: recent controversies and advances. Hippocampus 11 (2001) 8-17
6. Anagnostaras S.G., Gale G.D., and Fanselow M.S. The hippocampus and Pavlovian fear conditioning: reply to Bast et al. Hippocampus 12 (2002) 561-565
7. Bartfai T., Iverfeldt K., Fisone G., and Serfozo P. Regulation of the release of coexisting neurotransmitters. Annu Rev Pharmacol Toxicol 28 (1988) 285-310
8. Batten T.F., Gamboa-Esteves F.O., and Saha S. Evidence for peptide co-transmission in retrograde- and anterograde-labelled central nucleus of amygdala neurones projecting to NTS. Auton Neurosci 98 (2002) 28-32
9. Bechtholt A.J., Valentino R.J., and Lucki I. Overlapping and distinct brain regions associated with the anxiolytic effects of chlordiazepoxide and chronic fluoxetine. Neuropsychopharmacology 33 (2008) 2117-2130
10. Behan D.P., Khongsaly O., Liu X.J., Ling N., Goland R., Nasman B., et al. Measurement of corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in human plasma by two-site enzyme-linked immunoabsorbant assay. J Clin Endocrinol Metab 81 (1996) 2579-2586
11. Blanchard R.J., Yudko E.B., Rodgers R.J., and Blanchard D.C. Defense system Psychophamacol (Berl): an ethological approach to the pharmacology of fear and anxiety. Behav Brain Res 58 (1993) 155-165
12. Blanchard D.C., Griebel G., and Blanchard R.J. The mouse defense test battery: pharmacological and behavioral assays for anxiety and panic. Eur J Pharmacol 463 (2003) 97-116
13. Bourque C.W. Activity-dependent modulation of nerve terminal excitation in a mammalian peptidergic system. Trends Neurosci 14 (1991) 28-30
14. Bouton M.E., Westbrook R.F., Corcoran K.A., and Maren S. Contextual and temporal modulation of extinction: behavioral and biological mechanisms. Biol Psychiatry 60 (2006) 352-360
15. Brownstein M., Saavedra M.M., and Palkovits M. Norepinephrine and dopamine in the limbic system of the rat. Brain Res 79 (1974) 431-436
16. Campeau S., and Davis M. Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli. J Neurosci 15 (1995) 2301-2311
17. Cassell M.D., Gray T.S., and Kiss J.Z. Neuronal architecture in the rat central nucleus of the amygdala: a cytological, hodological, and immunocytochemical study. J Comp Neurol 246 (1986) 478-499
18. Cecchi M., Khoshbouei H., Javors M., and Morilak D.A. Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuroscience 112 (2002) 13-21
19. Cecchi M., Capriles N., Watson S.J., and Akil H. β1 adrenergic receptors in the bed nucleus of stria terminalis mediate differential responses to opiate withdrawal. Neuropsychopharmacology 32 (2007) 589-599
20. Chappell P.B., Smith M.A., Kilts C.D., Bissette G., Ritchie J., Anderson C., et al. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 6 (1986) 2908-2914
21. Chung W.C., DeVries G.J., and Swaab D.F. Sexual differentiation of the bed nucleus of the stria terminalis in humans may extend into adulthood. J Neurosci 22 (2002) 1027-1103
22. Ciccocioppo R., Fedeli A., Economidou D., Policani F., Weiss F., and Massi M. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ. J Neurosci 23 (2003) 9445-9451
23. Collins D.R., and Pare D. Reciprocal changes in the firing probability of lateral and central medial amygdala neurons. J Neurosci 19 (1999) 836-844
24. 2) receptors in the bed nucleus of the stria terminalis modulate conditioned defeat in syrian hamsters (Mesocricetus auratus). Behav Neurosci 119 (2005) 1042-1051
25. Crawley J., and Goodwin F.K. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazipines. Pharmacol Biochem Behav 13 (1980) 167
26. Crestani C.C., Alves F.H., Tavares R.F., and Correa F.M. Role of the bed nucleus of the stria terminalis in the cardiovascular responses to acute restraint stress in rats. Stress 1 (2008)
27. Davis M. The role of the amygdala in fear and anxiety. Annu Rev Neurosci 15 (1992) 353-375
28. Davis M. The role of the amygdala in conditioned and unconditioned fear and anxiety. In: Aggleton J.P. (Ed). The amygdala vol. 2 (2000), Oxford University Press, Oxford, United Kingdom 213-287
29. Davis M., and Whalen P. The amygdala: vigilance and emotion. Mol Psychiatry 6 (2001) 13-34
30. Davis M., Schlesinger L.S., and Sorenson C.A. Temporal specificity of fear-conditioning: effects of different conditioned stimulus-unconditioned stimulus intervals on the fear-potentiated startle effect. J Exp Psychol Anim Behav Process 15 (1989) 295-310
31. Day H.E., Curran E.J., Watson Jr. S.J., and Akil H. Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: evidence for their selective activation by interleukin-1β. J Comp Neurol 413 (1999) 113-128
32. Day H.E., Vittoz N.M., Oates M.M., Badiani A., Watson Jr. S.J., Robinson T.E., et al. A 6-hydroxydopamine lesion of the mesostriatal dopamine system decreases the expression of corticotropin releasing hormone and neurotensin mRNAs in the amygdala and bed nucleus of the stria terminalis. Brain Res 945 (2002) 151-159
33. de Jongh R., Groenink L., van der Gugten J., and Olivier B. The light-enhanced startle paradigm as a putative animal model for anxiety: effects of chlordiazepoxide, flesinoxan and fluvoxamine. Psychophamacology (Berl) 159 (2002) 176-180
34. de Jongh R., Groenink L., van der Gugten J., and Olivier B. Light-enhanced and fear-potentiated startle: temporal characteristics and effects of α-helical corticotropin-releasing hormone. Biol Psychiatry 54 (2003) 1041-1048
35. Deak T., Nguyen K.T., Ehrlich A.L., Watkins L.R., Spencer R.L., Maier S.F., et al. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology 140 (1999) 79-86
36. DeFries J.C., Hegmann J.P., and Weir M.W. Open-field behavior in mice: evidence for a major gene effect mediated by the visual system. Science 154 (1966) 1577-1579
37. Delfs J.M., Zhu Y., Druhan J.P., and Aston-Jones G. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403 (2000) 430-434
38. Deyama S., Nakagawa T., Kaneko S., Uehara T., and Minami M. Involvement of the bed nucleus of the stria terminalis in the negative affective component of visceral and somatic pain in rats. Behav Brain Res 176 (2007) 367-371
39. Deyama S., Katayama T., Kondoh N., Nakagawa T., Kaneko S., Yamaguchi T., et al. Role of enhanced noradrenergic transmission within the ventral bed nucleus of the stria terminalis in visceral pain-induced aversion in rats. Behav Brain Res 197 (2009) 279-283
40. Deyama S., Katayama T., Ohno A., Nakagawa T., Kaneko S., Yamaguchi T., et al. Activation of the β-adrenoceptor-protein kinase a signaling pathway within the ventral bed nucleus of the stria terminalis mediates the negative affective component of pain in rats. J Neurosci 28 (2008) 7728-7736
41. Di Fabio R., St-Denis Y., Sabbatini F.M., Andreotti D., Arban R., Bernasconi G., et al. Synthesis and pharmacological characterization of novel druglike corticotropin-releasing factor 1 antagonists. J Med Chem 51 (2008) 7370-7379
42. Dong H.W., and Swanson L.W. Organization of axonal projections from the anterolateral area of the bed nucleus of the stria terminalis. J Comp Neurol 468 (2004) 277-298
43. Dong H.W., Petrovich G.D., and Swanson L.W. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res- Brain Res Rev 38 (2001) 192-246
44. Dong H.W., Petrovich G.D., Watts A.G., and Swanson L.W. Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain. J Comp Neurol 436 (2001) 430-455
45. Eiden L.E., Hokfelt T., Brownstein M.J., and Palkovits M. Vasoactive intestinal polypeptide afferents to the bed nucleus of the stria terminalis in the rat: an immunohistochemical and biochemical study. Neuroscience 15 (1985) 999-1013
46. Erb S., Salmaso N., Rodaros D., and Stewart J. A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychophamacology (Berl) 158 (2001) 360-365
47. Fanselow M., and LeDoux J. Why we think plasticity underlying Pavlovian fear conditioning occurs in the basolateral amygdala. Neuron 23 (1999) 229-232
48. Fendt M., Siegl S., and Steiniger-Brach B. Noradrenaline transmission within the ventral bed nucleus of the stria terminalis is critical for fear behavior induced by trimethylthiazoline, a component of fox odor. J Neurosci 25 (2005) 5998-6004
49. File S.E., and Hyde J.R.G. Can social interaction be used to measure anxiety. Brit J Pharmacol 62 (1978) 19-24
50. Forray M.I., Andres M.E., Bustos G., and Gysling K. Regulation of endogenous noradrenaline release from the bed nucleus of stria terminalis. Biochem Pharmacol 49 (1995) 687-692
51. Forray M.I., Bustos G., and Gysling K. Regulation of norepinephrine release from the rat bed nucleus of the stria terminalis: in vivo microdialysis studies. J Neurosci Res 50 (1997) 1040-1046
52. Forray M.I., Gonzales M., Hadwed N., and Gonzalez M.P. Chronic immobilization stress increases glutamatergic transmission in the rat bed nucleus of the stria terminalis. In vivo microdialysis studies. Abstr Soc Neurosci (2005) Program No. 187.3)
53. Gewirtz J.C., McNish K.A., and Davis M. Lesions of the bed nucleus of the stria terminalis block sensitization of the acoustic startle reflex produced by repeated stress, but not fear-potentiated startle. Prog Neuro-Psychophamacol Biol Psychiat 22 (1998) 625-648
54. Goosens K.A., and Maren S. Contextual and auditory fear conditioning are mediated by the lateral, basal, and central amygdaloid nuclei in rats. Learn Mem 8 (2001) 148-155
55. Gray T.S., and Magnuson D.J. Neuropeptide neuronal efferents from the bed nucleus of the stria terminalis and central amygdaloid nucleus to the dorsal vagal complex in the rat. J Comp Neurol 262 (1987) 365-374
56. Gray T.S., and Magnuson D.J. Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat. Peptides 13 (1992) 451-460
57. Gray T.S., Piechowski R.A., Yracheta J.M., Rittenhouse P.A., Bethea C.L., and Van de Kar L.D. Ibotenic acid lesions in the bed nucleus of the stria terminalis attenuate conditioned stress-induced increases in prolactin, ACTH and corticosterone. Neuroendocrinology 57 (1993) 517-524
58. Grillon C. Models and mechanisms of anxiety: evidence from startle studies. Psychophamacology (Berl) 199 (2008) 421-437
59. Grillon C., Baas J.M., Pine D.S., Lissek S., Lawley M., Ellis V., et al. The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle. Biol Psychiatry 60 (2006) 760-766
60. Grillon C., Chavis C., Covington M.F., and Pine D.S. Two-week treatment with the selective serotonin reuptake inhibitor citalopram reduces contextual anxiety but not cued fear in healthy volunteers: a fear-potentiated startle study. Neuropsychopharmacology 34 (2009) 964-971
61. Grove E.A. Efferent connections of the substantia innominata in the rat. J Comp Neurol 277 (1988) 347-364
62. Guo J., Hazra R., and Rainnie D.G. Expression of potassium channel interacting proteins (KChIPs) and IA channel subunits in neurons of the anterolateral bed nucleus of stria terminalis (BNSTAL): modulation by stress?. Abstr Soc Neurosci (2007) (Program Number 98.5)
63. Hammack S.E., Richey K.J., Watkins L.R., and Maier S.F. Chemical lesion of the bed nucleus of the stria terminalis blocks the behavioral consequences of uncontrollable stress. Behav Neurosci 118 (2004) 443-448
64. Haring C., Humpel C., Skofitsch G., Krobath J., Javorsky F., and Saria A. Calcitonin gene-related peptide in the amygdaloid complex of the rat: immunohistochemical and quantitative distribution, and drug effects on calcium dependent, potassium-evoked in vitro release. Synapse 8 (1991) 261-269
65. Harrigan E.A., Magnuson D.J., Thunstedt G.M., and Gray T.S. Corticotropin releasing factor neurons are innervated by calcitonin gene-related peptide terminals in the rat central amygdaloid nucleus. Brain Res Bull 33 (1994) 529-534
66. Hatalski C.G., Guirguis C., and Baram T.Z. Corticotropin releasing factor mRNA expression in the hypothalamic paraventricular nucleus and the central nucleus of the amygdala is modulated by repeated acute stress in the immature rat. J Neuroendocrinol 10 (1998) 663-669
67. Hikichi T., Akiyoshi J., Yamamoto Y., Tsutsumi T., Isogawa K., and Nagayama H. Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526. Pharmacopsychiatry 33 (2000) 189-193
68. Hitchcock J.M., and Davis M. Lesions of the amygdala, but not of the cerebellum or red nucleus, block conditioned fear as measured with the potentiated startle paradigm. Behav Neurosci 100 (1986) 11-22
69. Hitchcock J.M., and Davis M. Fear-potentiated startle using an auditory conditioned stimulus: effect of lesions of the amygdala. Physiol Behav 39 (1987) 403-408
70. Hitchcock J.M., and Davis M. The efferent pathway of the amygdala involved in conditioned fear as measured with the fear-potentiated startle paradigm. Behav Neurosci 105 (1991) 826-842
71. Holstege G., Meiners L., and Tan K. Projections of the bed nucleus of the stria terminalis to the mesencephalon, pons, and medulla oblongata in the cat. Exp Brain Res 58 (1985) 379-391
72. Honkaniemi J. Colocalization of peptide- and tyrosine hydroxylase-like immunoreactivities with fos-immunoreactive neurons in rat central amygdaloid nucleus after immobilization stress. Brain Res 598 (1992) 107-113
73. Honkaniemi J., Pelto-Huikko M., Rechardt L., Isola J., Lammi A., Fuxe K., et al. Colocalization of peptide and glucocorticoid receptor immunoreactivities in rat central amygdaloid nucleus. Neuroendocrinology 55 (1992) 451-459
74. Hopkins D.A., and Holstege G. Amygdaloid projections to the mesencephalon, pons and medulla oblongata in the cat. Exp Brain Res 32 (1978) 529-547
75. Hsu D.T., Chen F.L., Takahashi L.K., and Kalin N.H. Rapid stress-induced elevations in corticotropin-releasing hormone mRNA in rat central amygdala nucleus and hypothalamic paraventricular nucleus: an in situ hybridization analysis. Brain Res 788 (1998) 305-310
76. Huber D., Veinante P., and Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 308 (2005) 245-248
77. Ip N.Y. Pattern of presynaptic nerve activity can determine the type of neurotransmitter regulating a postsynaptic event. Nature 311 (1994) 472-474
78. Iwata J., LeDoux J.E., Meeley M.P., Arneric S., and Reis D.J. Intrinsic neurons in the amygdala field projected to by the medial geniculate body mediate emotional responses conditioned to acoustic stimuli. Brain Res 383 (1986) 195-214
79. Jasnow A.M., Davis M., and Huhman K.L. Involvement of central amygdalar and bed nucleus of the stria terminalis corticotropin-releasing factor in behavioral responses to social defeat. Behav Neurosci 118 (2004) 1052-1061
80. Johnston J.B. Further contributions to the study of the evolution of the forebrain. J Comp Neurol 35 (1923) 337-481
81. Jolkkonen E., and Pitkanen A. Intrinsic connections of the rat amygdaloid complex: projections originating in the central nucleus. J Comp Neurol 395 (1998) 53-72
82. Ju G., Swanson L.W., and Simerly R.B. Studies on the cellular architecture of the bed nuclei of the stria terminalis in the rat: II. chemoarchitecture. J Comp Neurol 280 (1989) 603-621
83. Justice N.J., Yuan Z.F., Sawchenko P.E., and Vale W. Type 1 corticotropin-releasing factor receptor expression reported in bac transgenic mice: implications for reconciling ligand-receptor mismatch in the central corticotropin-releasing factor system. J Comp Neurol 511 (2008) 479-496
84. Kalin N.H. Brain regions associated with the expression and contextual regulation of anxiety in primates. Biol Psychiatry 58 (2005) 796-804
85. Kalin N.H., and Takahashi L.K. Fear-motivated behavior induced by prior shock experience is mediated by corticotropin-releasing hormone systems. Brain Res 509 (1990) 80-84
86. Kalin N.H., Takahashi L.K., and Chen F.L. Restraint stress increases corticotropin-releasing hormone mRNA content in the amygdala and paraventricular nucleus. Brain Res 656 (1994) 182-186
87. Kash T.L., Nobis W.P., Matthews R.T., and Winder D.G. Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process. J Neurosci 28 (2008) 13856-13865
88. Kehne J.H., Gallager D.W., and Davis M. Strychnine: brainstem and spinal mediation of excitatory effects on acoustic startle. Eur J Pharmacol 76 (1981) 177-186
89. Kiernan M.J., Westbrook R.F., and Cranney J. Immediate shock, passive avoidance, and potentiated startle: implications for the unconditioned response to shock. Animal Learn Behav 23 (1995) 22-30
90. Kilts C., and Anderson C. The simultaneous quantification of dopamine, norepinephrine and epinephrine in micropunched rat brain nuclei by on-line trace enrichment HPLC with electro-chemical detection distribution of catecholamines in the limbic system. Neurochem Int 9 (1986) 437-455
91. Koo J.W., Han J.S., and Kim J.J. Selective neurotoxic lesions of basolateral and central nuclei of the amygdala produce differential effects on fear conditioning. J Neurosci 24 (2004) 7654-7662
92. LeDoux J.E., Iwata J., Cicchetti P., and Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci 8 (1988) 2517-2529
93. Lee Y., and Davis M. Role of the hippocampus, bed nucleus of the stria terminalis and amygdala in the excitatory effect of corticotropin releasing hormone on the acoustic startle reflex. J Neurosci 17 (1997) 6434-6446
94. Lee Y., Fitz S., Johnson P.L., and Shekhar A. Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety. Neuropsychopharmacology 33 (2008) 2586-2594
95. Lesur A., Gaspar P., Alvarez C., and Berger B. Chemoanatomic compartments in the human bed nucleus of the stria terminalis. Neuroscience 32 (1989) 181-194
96. Liang K.C., Melia K.R., Campeau S., Falls W.A., Miserendino M.J.D., and Davis M. Lesions of the central nucleus of the amygdala, but not of the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin releasing factor on the acoustic startle reflex. J Neurosci 12 (1992) 2313-2320
97. Liang K.C., Melia K.R., Miserendino M.J.D., Falls W.A., Campeau S., and Davis M. Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex. J Neurosci 12 (1992) 2303-2312
98. Liang K.C., Chen H.C., and Chen D.Y. Posttraining infusion of norepinephrine and corticotropin releasing factor into the bed nucleus of the stria terminalis enhanced retention in an inhibitory avoidance task. Chin J Physiol 44 (2001) 33-43
99. Lino-de-Oliveira C., Sales A.J., Del Bel E.A., Silveira M.C., and Guimaraes F.S. Effects of acute and chronic fluoxetine treatments on restraint stress-induced fos expression. Brain Res Bull 55 (2001) 747-754
100. Lundberg J.M., Rudehill A., and Sollevi A. Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide y from pig spleen. Neurosci Lett 63 (1986) 96-100
101. Makino S., Gold P.W., and Schulkin J. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res 640 (1994) 105-112
102. Makino S., Shibasaki T., Yamauchi N., Nishioka T., Mimoto T., Wakabayashi I., et al. Psychological stress increased corticotropin-releasing hormone mRNA and content in the central nucleus of the amygdala but not in the hypothalamic paraventricular nucleus in the rat. Brain Res 850 (1999) 136-143
103. Maren S. Neurobiology of Pavlovian fear conditioning. Annu Rev Neurosci 24 (2001) 897-931
104. Markham C.M., Norvelle A., and Huhman K.L. Role of the bed nucleus of the stria terminalis in the acquisition and expression of conditioned defeat in syrian hamsters. Behav Brain Res 198 (2009) 69-73
105. McDonald A.J. Cytoarchitecture of the central amygdaloid nucleus of the rat. J Comp Neurol 208 (1982) 401-418
106. McDonald A.J. Coexistence of somatostatin with neuropeptide Y, but not with cholecystokinin or vasoactive intestinal peptide, in neurons of the rat amygdala. Brain Res 500 (1989) 37-45
107. McNish K.A., Gewirtz J.C., and Davis M. Evidence of contextual fear conditioning following lesions of the hippocampus: a disruption of freezing but not fear-potentiated startle. J Neurosci 17 (1997) 9353-9360
108. McNish K.A., Gewirtz J.C., and Davis M. Disruption of contextual freezing, but not contextual blocking of fear-potentiated startle, after lesions of the dorsal hippocampus. Behav Neurosci 114 (2000) 64-76
109. Meloni E.G., and Davis M. Enhancement of the acoustic startle response in rats by the dopamine D1 receptor agonist SKF82958. Psychophamacology (Berl) 144 (1999) 373-380
110. Meloni E.G., Gerety L.P., Knoll A.T., Cohen B.M., and Carlezon Jr. W.A. Behavioral and anatomical interactions between dopamine and corticotropin-releasing factor in the rat. J Neurosci 26 (2006) 3855-3863
111. Meloni E.G., Jackson A., Gerety L.P., Cohen B.M., and Carlezon Jr. W.A. Role of the bed nucleus of the stria terminalis (BST) in the expression of conditioned fear. Ann N Y Acad Sci 1071 (2006) 538-541
112. Moga M.M., and Gray T.S. Evidence for corticotropin-releasing factor, neurotensin, and somatostatin in the neural pathway from the central nucleus of the amygdala to the parabrachial nucleus. J Comp Neurol 241 (1985) 275-284
113. Moga M.M., Saper C.B., and Gray T.S. Bed nucleus of the stria terminalis: cytoarchitecture, immunohistochemistry, and projection to the parabrachial nucleus in the rat. J Comp Neurol 283 (1989) 315-332
114. Morilak D.A., Cecchi M., and Khoshbouei H. Interactions of norepinephrine and galanin in the central amygdala and lateral bed nucleus of the stria terminalis modulate the behavioral response to acute stress. Life Sci 73 (2003) 715-726
115. Nakagawa T., Yamamoto R., Fujio M., Suzuki Y., Minami M., Satoh M., et al. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats. Neuroscience 134 (2005) 9-19
116. Nijsen M.J.M.A., Croiset G., Diamant M., De Wied D., and Wiegant V.M. CRH signalling in the bed nucleus of the stria terminalis is involved in stress-induced cardiac vagal activation in conscious rats. Neuropsychopharmacology 24 (2001) 1-10
117. Nose I., Higashi H., Inokuchi H., and Nishi S. Synaptic responses of guinea pig and rat central amygdala neurons in vitro. J Neurophysiol 65 (1991) 1227-1241
118. Olive M.F., Koenig H.N., Nannini M.A., and Hodge C.W. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol Biochem Behav 72 (2002) 213-220
119. Otake K., and Nakamura Y. Sites of origin of corticotropin-releasing factor-like immunoreactive projection fibers to the paraventricular thalamic nucleus in the rat. Neurosci Lett 201 (1995) 84-86
120. Otto T., and Poon P. Dorsal hippocampal contributions to unimodal contextual conditioning. J Neurosci 26 (2006) 6603-6609
121. Pacak K., McCarty R., Palkovits M., Kopin I.J., and Goldstein D.S. Effects of immobilization on in vivo release of norepinephrine in the bed nucleus of the stria terminalis in conscious rats. Brain Res 688 (1995) 242-246
122. Pardon M.C., Gould G.G., Garcia A., Phillips L., Cook M.C., Miller S.A., et al. Stress reactivity of the brain noradrenergic system in three rat strains differing in their neuroendocrine and behavioral responses to stress: implications for susceptibility to stress-related neuropsychiatric disorders. Neuroscience 115 (2002) 229-242
123. Pare D., Quirk G.J., and Ledoux J.E. New vistas on amygdala networks in conditioned fear. J Neurophysiol 92 (2004) 1-9
124. Parsons T.C., and Otto T. Temporary inactivation of dorsal hippocampus attenuates explicitly nonspatial, unimodal, contextual fear conditioning. Neurobiol Learn Mem 90 (2008) 261-268
125. Pego J.M., Morgado P., Pinto L.G., Cerqueira J.J., Almeida O.F., and Sousa N. Dissociation of the morphological correlates of stress-induced anxiety and fear. Eur J Neurosci 27 (2008) 1503-1516
126. Petrovich G.D., and Swanson L.W. Projections from the lateral part of the central amygdalar nucleus to the postulated fear conditioning circuit. Brain Res 763 (1997) 247-254
127. Peyron C., Petit J.M., Rampon C., Jouvet M., and Luppi P.H. Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neuroscience 82 (1998) 443-468
128. Phelix C.F., Liposits Z., and Paull W.K. Catecholamine-CRF synaptic interaction in a septal bed nucleus: afferents of neurons in the bed nucleus of the stria terminalis. Brain Res Bull 33 (1994) 109-119
129. Pitkanen A. Connectivity of the rat amygdala complex. In: Aggleton J.P. (Ed). Amygdala (2000), Oxford University Press, New York 31-116
130. Potter E., Sutton S., Donaldson C., Chen R., Perrin M., Lewis K., et al. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 91 (1994) 8777-8781
131. Resstel L.B., Alves F.H., Reis D.G., Crestani C.C., Correa F.M., and Guimaraes F.S. Anxiolytic-like effects induced by acute reversible inactivation of the bed nucleus of stria terminalis. Neuroscience 154 (2008) 869-876
132. Richardson R. Shock sensitization of startle: learned or unlearned fear?. Behav Brain Res 110 (2000) 109-117
133. Risbrough V.B., Geyer M.A., Hauger R.L., Coste S., Stenzel-Poore M., Wurst W., et al. CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues. Neuropsychopharmacology 34 (2008) 1494-1503
134. Roberts G.W., Woodhams P.L., Crow T.J., and Polak J.M. Loss of immunoreactive vip in the bed nucleus following lesions of the stria terminalis. Brain Res 195 (1980) 471-475
135. Roberts G.W., Woodhams P.L., Polak J.M., and Crow T.J. Distribution of neuropeptides in the limbic system of the rat: the amygdaloid complex. Neuroscience 7 (1982) 99-131
136. Rosen J.B., Hitchcock J.M., Sananes C.B., Miserendino M.J.D., and Davis M. A direct projection from the central nucleus of the amygdala to the acoustic startle pathway: anterograde and retrograde tracing studies. Behav Neurosci 105 (1991) 817-825
137. Sah P., Faber E.S., Lopez De Armentia M., and Power J. The amygdaloid complex: anatomy and physiology. Physiol Rev 83 (2003) 803-834
138. Sahuque L.L., Kullberg E.F., McGeehan A.J., Kinder J.R., Hicks M.P., Blanton M.G., et al. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychophamacology (Berl) 186 (2006) 122-132
139. Sajdyk T., Johnson P., Fitz S., and Shekhar A. Chronic inhibition of GABA synthesis in the bed nucleus of the stria terminalis elicits anxiety-like behavior. J Psychophamacol 22 (2008) 633-641
140. Sakanaka M., Shiosaka S., Takatsuki K., Inagaki S., Takagi H., Senba E., et al. Experimental immunohistochemical studies on the amygdalofugal peptidergic (substance P and somatostatin) fibers in the stria terminalis of the rat. Brain Res 221 (1981) 231-242
141. Sakanaka M., Shibasaki T., and Lederis K. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res 382 (1986) 213-238
142. Sananes C.B., and Davis M. N-methyl-d-aspartate lesions of the lateral and basolateral nuclei of the amygdala block fear-potentiated startle and shock sensitization of startle. Behav Neurosci 106 (1992) 72-80
143. Santibanez M., Gysling K., and Forray M.I. Desipramine prevents the sustained increase in corticotropin-releasing hormone-like immunoreactivity induced by repeated immobilization stress in the rat central extended amygdala. J Neurosci Res 84 (2006) 1270-1281
144. Schmued L.C. Diagonal ventral forebrain continuum has overlapping telencephalic inputs and brainstem outputs which may represent loci for limbic/autonomic integration. Brain Res 667 (1994) 175-191
145. Schwaber J.S., Kapp B.S., Higgins G.A., and Rapp P.R. Amygdaloid and basal forebrain direct connections with the nucleus of the solitary tract and the dorsal motor nucleus. J Neurosci 2 (1982) 1424-1438
146. Shekhar A., McCann U.D., Meaney M.J., Blanchard D.C., Davis M., Frey K.A., et al. Summary of a national institute of mental health workshop: developing animal models of anxiety disorders. Psychophamacology (Berl) 157 (2001) 327-339
147. Shepard J.D., Barron K.W., and Myers D.A. Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Res 861 (2000) 288-295
148. Shimada S., Inagaki S., Kubota Y., Kito S., Funaki H., and Takagi H. Light and electron microscopic studies of calcitonin gene-related peptide-like immunoreactive terminals in the central nucleus of the amygdala and the bed nucleus of the stria terminalis of the rat. Exp Brain Res 77 (1989) 217-220
149. Shimada S., Inagaki S., Kubota Y., Ogawa N., Shibasaki T., and Takagi H. Coexistence of peptides (corticotropin releasing factor/neurotensin and substance P/somatostatin) in the bed nucleus of the stria terminalis and central amygdaloid nucleus of the rat. Neuroscience 30 (1989) 377-383
150. Singewald N., Salchner P., and Sharp T. Induction of c-fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry 53 (2003) 275-283
151. Stout S.C., Mortas P., Owens M.J., Nemeroff C.B., and Moreau J. Increased corticotropin-releasing factor concentrations in the bed nucleus of the stria terminalis of anhedonic rats. Eur J Pharmacol 401 (2000) 39-46
152. Straube T., Mentzel H.J., and Miltner W.H. Waiting for spiders: brain activation during anticipatory anxiety in spider phobics. Neuroimage 37 (2007) 1427-1436
153. Sullivan G.M., Apergis J., Bush D.E., Johnson L.R., Hou M., and Ledoux J.E. Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience 128 (2004) 7-14
154. Sun N., and Cassell M.D. Intrinsic GABAergic neurons in the rat central extended amygdala. J Comp Neurol 330 (1993) 381-404
155. Swerdlow N.R., Geyer M.A., Vale W.W., and Koob G.F. Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychophamacology (Berl) 88 (1986) 147-152
156. Thompson B.L., Erickson K., Schulkin J., and Rosen J.B. Corticosterone facilitates retention of contextually conditioned fear and increases CRH mRNA expression in the amygdala. Behav Brain Res 149 (2004) 209-215
157. Toufexis D. Region- and sex-specific modulation of anxiety behaviours in the rat. J Neuroendocrinol 19 (2007) 461-473
158. Van de Kar L.D., Piechowski R.A., Rittenhouse P.A., and Gray T.S. Amygdaloid lesions: Differential effect on conditioned stress and immobilization-induced increases in cortiocosterone and renin secretion. Neuroendocrinology 15 (1991) 89-95
159. Van Nobelen M., and Kokkinidis L. Amygdaloid GABA, not glutamate neurotransmission or mRNA transcription controls footshock-associated fear arousal in the acoustic startle paradigm. Neuroscience 137 (2006) 707-716
160. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428 (2000) 191-212
161. Veening J.G., Swanson L.W., and Sawchenko P.E. The organization of projections from the central nucleus of the amygdala to brain stem sites involved in central autonomic regulation: a combined retrograde transport-immunohistochemical study. Brain Res 303 (1984) 337-357
162. Vinkers C.H., Risbrough V.B., Geyer M.A., Caldwell S., Low M.J., and Hauger R.L. Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating. Pharmacol Biochem Behav 86 (2007) 550-558
163. Vyas A., Bernal S., and Chattarji S. Effects of chronic stress on dendritic arborization in the central and extended amygdala. Brain Res 965 (2003) 290-294
164. Waddell J., Morris R.W., and Bouton M.E. Effects of bed nucleus of the stria terminalis lesions on conditioned anxiety: aversive conditioning with long-duration conditional stimuli and reinstatement of extinguished fear. Behav Neurosci 120 (2006) 324-336
165. Waddell J., Bouton M.E., and Falls W.A. Central CRF receptor antagonist α-helical CRF9-41 blocks reinstatement of extinguished fear: the role of the bed nucleus of the stria terminalis. Behav Neurosci 122 (2008) 1061-1069
166. Walker D.L., and Davis M. Anxiogenic effects of high illumination levels assessed with the acoustic startle paradigm. Biol Psychiatry 42 (1997) 461-471
167. Walker D.L., and Davis M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in light-enhanced versus fear-potentiated startle. J Neurosci 17 (1997) 9375-9383
168. Walker D.L., and Davis M. Light-enhanced startle: further pharmacological and behavioral characterization. Psychophamacology (Berl) 159 (2002) 304-310
169. Walker D.L., and Davis M. Quantifying fear potentiated startle using absolute versus percent increase scoring methods: implications for the neurocircuitry of fear and anxiety. Psychophamacology (Berl) 164 (2002) 318-328
170. Walker D.L., and Davis M. The role of glutamate receptors within the amygdala in fear learning, fear-potentiated startle, and extinction. Pharmacol Biochem Behav 71 (2002) 379-392
171. Walker D.L., Yang Y., Ratti E., Corsi M., Trist D., and Davis M. Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and crf-enhanced startle suggest preferential involvement in sustained vs phasic threat responses. Neuropsychopharmacology 34 (2008) 1533-1542
172. Walter A., Mai J.K., Lanta L., and Gorcs T. Differential distribution of immunohistochemical markers in the bed nucleus of the stria terminalis in the human brain. J Chem Neuroanat 4 (1991) 281-298
173. Watts A.G., and Sanchez-Watts G. Region-specific regulation of neuropeptide mRNAs in rat limbic forebrain neurones by aldosterone and corticosterone. J Physiol 484 (1995) 721-736
174. Whim M.D. Frequency-dependent release of peptide cotransmitters from identified cholinergic motor neurons in aplysia. Proc Natl Acad USA 86 (1989) 9034-9038
175. Wilensky A.E., Schafe G.E., Kristensen M.P., and LeDoux J.E. Rethinking the fear circuit: the central nucleus of the amygdala is required for the acquisition, consolidation, and expression of Pavlovian fear conditioning. J Neurosci 26 (2006) 12387-12396
176. Woodhams P.L., Roberts G.W., Polak J.M., and Crow T.J. Distribution of neuropeptides in the limbic system of the rat: the bed nucleus of the stria terminalis, septum and preoptic area. Neuroscience 8 (1983) 677-703
177. Wray S., and Hoffman G.E. Organization and interrelationship of neuropeptides in the central amygdaloid nucleus of the rat. Peptides 4 (1983) 525-541
178. Wynn P.C., Hauger R.L., Holmes M.C., Millan M.A., Catt K.J., and Aguilera G. Brain and pituitary receptors for corticotropin releasing factor: localization and differential regulation after adrenalectomy. Peptides 5 (1984) 1077-1084
179. Zimmerman J.M., Rabinak C.A., McLachlan I.G., and Maren S. The central nucleus of the amygdala is essential for acquiring and expressing conditional fear after overtraining. Learn Mem 14 (2007) 634-644